JPRN-UMIN000001802
Completed
Phase 4
Investigation of effective treatment of nocturnal hypertension in diabetes - Treatment of nocternal hypertension in diabetes with new blood pressure measureing method
Kobe University Graduate School of Medicine Division of deabetes, metabolism and endocrinology0 sites50 target enrollmentJuly 1, 2009
Conditionsocturnal hypertension in type 2 DM
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- octurnal hypertension in type 2 DM
- Sponsor
- Kobe University Graduate School of Medicine Division of deabetes, metabolism and endocrinology
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) patients with secondary hypertension 2\) patients with liver dysfunction (GPT over three times the normal value) 3\) patients with renal failure (serum creatinine over 2\.0 mg/dL) 4\) patients with bilareral renal artery stenosis 5\) pregnant or possible pregnant women 6\) patients with a history of hypersensitivity to Losartan or thiazide
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Sleep positional therapy for the treatment of nocturnal gastroesophageal refluxgastroesophageal reflux disease10017977NL-OMON52836Academisch Medisch Centrum45
Recruiting
Not Applicable
Sleep positional therapy for the treatment of nocturnal gastroesophageal refluxNL-OMON21478Amsterdam UMC45
Completed
Not Applicable
Comparison of two regimens in the treatment of nocturnal enuresisIRCT2012090610758N1Tabriz University of Medical Sciences100
Active, not recruiting
Not Applicable
Polychromatic Light Treatment for Long-COVIDong CovidLong CovidNeurological - Other neurological disordersACTRN12623000118606The Bronowski Institute of Behavioural Neuroscience3
Completed
Not Applicable
Effective Treatment for Elevated Nighttime-Home Blood Pressure in Patients with Hypertension (Prognostic Value of Nighttime Home Blood Pressure Reduction)HypertensionJPRN-UMIN000019173Department of Cardiovascular Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University514